Literature DB >> 26077571

Interferon regulatory factor signalings in cardiometabolic diseases.

Xiao-Jing Zhang1, Peng Zhang1, Hongliang Li2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26077571     DOI： 10.1161/HYPERTENSIONAHA.115.04898

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  11 in total

1.  A Western-type dietary pattern and atorvastatin induce epicardial adipose tissue interferon signaling in the Ossabaw pig.

Authors:  Maura E Walker; Nirupa R Matthan; Gloria Solano-Aguilar; Saebyeol Jang; Sukla Lakshman; Aleksey Molokin; Tyler Faits; Joseph F Urban; W Evan Johnson; Stefania Lamon-Fava; Alice H Lichtenstein
Journal:  J Nutr Biochem       Date:  2019-02-20       Impact factor: 6.048

2.  Transcription factor motif activity as a biomarker of muscle aging.

Authors:  Anastasiya Börsch; Mihaela Zavolan
Journal:  Am J Aging Sci Res       Date:  2021

3.  PDGFR-β modulates vascular smooth muscle cell phenotype via IRF-9/SIRT-1/NF-κB pathway in subarachnoid hemorrhage rats.

Authors:  Weifeng Wan; Yan Ding; Zongyi Xie; Qian Li; Feng Yan; Enkhjargal Budbazar; William J Pearce; Richard Hartman; Andre Obenaus; John H Zhang; Yong Jiang; Jiping Tang
Journal:  J Cereb Blood Flow Metab       Date:  2018-02-26       Impact factor: 6.200

4.  Angiotensin-Converting Enzyme 3 (ACE3) Protects Against Pressure Overload-Induced Cardiac Hypertrophy.

Authors:  Chang-Jiang Yu; Liang-Liang Tang; Chen Liang; Xiao Chen; Shu-Ying Song; Xiao-Qing Ding; Kun-Yu Zhang; Bin-Lin Song; Dan Zhao; Xue-Yong Zhu; Hong-Liang Li; Zhi-Ren Zhang
Journal:  J Am Heart Assoc       Date:  2016-02-18       Impact factor: 5.501

5.  Carboxyl-Terminal Modulator Protein Ameliorates Pathological Cardiac Hypertrophy by Suppressing the Protein Kinase B Signaling Pathway.

Authors:  Xiaoxiong Liu; Qin Yang; Li-Hua Zhu; Jia Liu; Ke-Qiong Deng; Xue-Yong Zhu; Ye Liu; Jun Gong; Peng Zhang; Shuyan Li; Hao Xia; Zhi-Gang She
Journal:  J Am Heart Assoc       Date:  2018-06-26       Impact factor: 5.501

6.  The expression profiling of microRNA in systemic sclerosis-associated pulmonary arterial hypertension.

Authors:  Yu-Xia Huang; Fei Li; Dong Liu; Yuan-Yuan Sun; Qin-Hua Zhao; Rong Jiang; Lan Wang; Ping Yuan; Jin-Ming Liu; Yue Wu; Ji Zhang
Journal:  Ann Transl Med       Date:  2021-09

7.  Tripartite motif 32 prevents pathological cardiac hypertrophy.

Authors:  Lijuan Chen; Jia Huang; Yanxiao Ji; Xiaojing Zhang; Pixiao Wang; Keqiong Deng; Xi Jiang; Genshan Ma; Hongliang Li
Journal:  Clin Sci (Lond)       Date:  2016-02-16       Impact factor: 6.124

8.  NULP1 Alleviates Cardiac Hypertrophy by Suppressing NFAT3 Transcriptional Activity.

Authors:  Xin Zhang; Fang Lei; Xiao-Ming Wang; Ke-Qiong Deng; Yan-Xiao Ji; Yan Zhang; Hongliang Li; Xiao-Dong Zhang; Zhibing Lu; Peng Zhang
Journal:  J Am Heart Assoc       Date:  2020-08-04       Impact factor: 5.501

9.  The Role of the NOD1/Rip2 Signaling Pathway in Myocardial Remodeling in Spontaneously Hypertensive Rats.

Authors:  Feng-Yi Liu; Bing-Qian Fang; Ling-Min Sun; Xiu-Zhen Zhang; Jin-Li Liu; Yun Yang; Wen-Hua Zhang; Xiu-Li Wang; Yan-Chun Ding
Journal:  Med Sci Monit       Date:  2020-08-28

10.  Genome-Wide DNA Methylation Signatures Predict the Early Asymptomatic Doxorubicin-Induced Cardiotoxicity in Breast Cancer.

Authors:  Michael A Bauer; Valentina K Todorova; Annjanette Stone; Weleetka Carter; Matthew D Plotkin; Ping-Ching Hsu; Jeanne Y Wei; Joseph L Su; Issam Makhoul
Journal:  Cancers (Basel)       Date:  2021-12-15       Impact factor: 6.575
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.